Sriram Gubbi
Molecular Biology · 2020
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 30 citations into it
- Endocrinology, Diabetes and Metabolism — 6 citations into it
Whom Sriram Gubbi trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- C. Bailey (in Molecular Biology)
Papers from Sriram Gubbi's perspective
Ordered by how strongly the researchers Sriram Gubbi trusts endorse each paper. Same corpus, a different order for every researcher.
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase (Nature)
- Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. (Biochemical Journal)
- Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders (Nature)
- Metformin and the gastrointestinal tract (Diabetologia)
- Metformin as a Tool to Target Aging (Cell Metabolism)
- The hallmarks of aging. (Cell)
- Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status (Circulation Research)
- Proteostasis and aging (Nature Medicine)
- The proteostasis network and its decline in ageing (Nature reviews. Molecular cell biology)
- Gut microbiota and intestinal FXR mediate the clinical benefits of metformin (Nature Medicine)
Their papers
- Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) — 641 citations
- COVID-19 pandemic, coronaviruses, and diabetes mellitus (2020) — 708 citations